Linking disease-associated genes to regulatory networks via promoter organization

Nucleic Acids Res. 2005 Feb 8;33(3):864-72. doi: 10.1093/nar/gki230. Print 2005.

Abstract

Pathway- or disease-associated genes may participate in more than one transcriptional co-regulation network. Such gene groups can be readily obtained by literature analysis or by high-throughput techniques such as microarrays or protein-interaction mapping. We developed a strategy that defines regulatory networks by in silico promoter analysis, finding potentially co-regulated subgroups without a priori knowledge. Pairs of transcription factor binding sites conserved in orthologous genes (vertically) as well as in promoter sequences of co-regulated genes (horizontally) were used as seeds for the development of promoter models representing potential co-regulation. This approach was applied to a Maturity Onset Diabetes of the Young (MODY)-associated gene list, which yielded two models connecting functionally interacting genes within MODY-related insulin/glucose signaling pathways. Additional genes functionally connected to our initial gene list were identified by database searches with these promoter models. Thus, data-driven in silico promoter analysis allowed integrating molecular mechanisms with biological functions of the cell.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Computational Biology / methods*
  • Diabetes Mellitus, Type 2 / genetics
  • Gene Expression Regulation*
  • Genetic Predisposition to Disease*
  • Humans
  • Phylogeny
  • Promoter Regions, Genetic*
  • Sequence Analysis, DNA / methods*
  • Transcription Factors / metabolism

Substances

  • Transcription Factors